https://www.selleckchem.com/pr....oducts/RO4929097.htm
Bioinformatic analysis indicated that c.37GT(p.E13*) was a pathogenic mutation, while the c.694AG (p.T232A) was considered to be likely pathogenic. MS/MS screening on PCD contributed to the early diagnosis and screening. In addition, SLC22A5 gene mutation analysis contributed to the PCD screening. MS/MS screening on PCD contributed to the early diagnosis and screening. In addition, SLC22A5 gene mutation analysis contributed to the PCD screening. Disparities in colon cancer (CC) outcomes may be due to a more aggressive phenotyp